Skip to Main Content

Paper Details

Clinical non-effectiveness of clopidogrel use for peripheral artery disease in patients with CYP2C19 polymorphisms: a systematic review.
Eur J Clin Pharmacol
3
2022
CYP2C19, CYP2C19 LOF alleles, CYP2C19 loss of function (LOF, CYP2C19 loss of function (LOF) alleles, PAD, clopidogrel, patient, patients, peripheral artery disease, restenosis
Author NameAffiliation
Michael T EadonIndiana University School of Medicine
Titus SchleyerIndiana University School of Medicine
Titus SchleyerCenter for Biomedical Informatics, Regenstrief Institute
  • 1 - 3

Datasets

PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink